» Articles » PMID: 25185554

Misfolding of VWF to Pathologically Disordered Conformations Impacts the Severity of Von Willebrand Disease

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2014 Sep 5
PMID 25185554
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The primary hemostatic von Willebrand factor (vWF) functions to sequester platelets from rheological blood flow and mediates their adhesion to damaged subendothelium at sites of vascular injury. We have surveyed the effect of 16 disease-causing mutations identified in patients diagnosed with the bleeding diathesis disorder, von Willebrand disease (vWD), on the structure and rheology of vWF A1 domain adhesiveness to the platelet GPIbα receptor. These mutations have a dynamic phenotypical range of bleeding from lack of platelet adhesion to severe thrombocytopenia. Using new rheological tools in combination with classical thermodynamic, biophysical, and spectroscopic metrics, we establish a high propensity of the A1 domain to misfold to pathological molten globule conformations that differentially alter the strength of platelet adhesion under shear flow. Rheodynamic analysis establishes a quantitative rank order between shear-rate-dependent platelet-translocation pause times that linearly correlate with clinically reported measures of patient platelet counts and the severity of thrombocytopenia. These results suggest that specific secondary structure elements remaining in these pathological conformations of the A1 domain regulate GPIbα binding and the strength of vWF-platelet interactions, which affects the vWD functional phenotype and the severity of thrombocytopenia.

Citing Articles

Conformation-specific RNA aptamers for phenotypic distinction between normal von Willebrand factor and type 2B von Willebrand disease.

Machha V, Tischer A, Moon-Tasson L, Tange J, Santiago-Davis A, Pruthi R NAR Mol Med. 2024; 1(4):ugae021.

PMID: 39719968 PMC: 11664255. DOI: 10.1093/narmme/ugae021.


Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A.

Seidizadeh O, Mollica L, Zambarbieri S, Baronciani L, Cairo A, Colpani P Blood Adv. 2024; 8(7):1725-1736.

PMID: 38315875 PMC: 10997909. DOI: 10.1182/bloodadvances.2024012626.


Molecular mechanisms of catch bonds and their implications for platelet hemostasis.

Belyaev A, Fedotova I Biophys Rev. 2023; 15(5):1233-1256.

PMID: 37974999 PMC: 10643804. DOI: 10.1007/s12551-023-01144-8.


Removal of the vicinal disulfide enhances the platelet-capturing function of von Willebrand factor.

Tischer A, Moon-Tasson L, Auton M Blood. 2023; 141(12):1469-1473.

PMID: 36603190 PMC: 10082372. DOI: 10.1182/blood.2022018803.


Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain.

Legan E, Liu Y, Arce N, Parker E, Lollar P, Zhang X Blood. 2022; 141(10):1221-1232.

PMID: 36580664 PMC: 10023833. DOI: 10.1182/blood.2022017239.


References
1.
Tischer A, Auton M . Urea-temperature phase diagrams capture the thermodynamics of denatured state expansion that accompany protein unfolding. Protein Sci. 2013; 22(9):1147-60. PMC: 3776328. DOI: 10.1002/pro.2301. View

2.
Lillicrap D . Genotype/phenotype association in von Willebrand disease: is the glass half full or empty?. J Thromb Haemost. 2009; 7 Suppl 1:65-70. DOI: 10.1111/j.1538-7836.2009.03367.x. View

3.
Schrank T, Bolen D, Hilser V . Rational modulation of conformational fluctuations in adenylate kinase reveals a local unfolding mechanism for allostery and functional adaptation in proteins. Proc Natl Acad Sci U S A. 2009; 106(40):16984-9. PMC: 2761315. DOI: 10.1073/pnas.0906510106. View

4.
Springer T . Biology and physics of von Willebrand factor concatamers. J Thromb Haemost. 2011; 9 Suppl 1:130-43. PMC: 4117350. DOI: 10.1111/j.1538-7836.2011.04320.x. View

5.
Kitchen S, Jennings I, Woods T, Kitchen D, Walker I, Preston F . Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation. Semin Thromb Hemost. 2006; 32(5):492-8. DOI: 10.1055/s-2006-947863. View